Amesite Inc. (AMST) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $1.32 et chiffre d'affaires de $0.01B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-1.73 vs est $1.32 (manqué -231.1%). 2025: réel $-1.03 vs est $1.32 (manqué -178%). Précision des analystes: 0%.
Estimations du BPA — AMST
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.73
vs Est $1.32
▼ 176.3% off
2025
Actual –$1.03
vs Est $1.32
▼ 228.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.
Estimations du CA — AMST
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.010B
▼ 6,012.1% off
2025
Actual $0.000B
vs Est $0.010B
▼ 9,134.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Les autres consultent aussi
